Thursday 22 September 2022

PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection - Business Wire

PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection  Business Wire

from "phlebotomist" - Google News https://bwnews.pr/3qYnskb

No comments:

Post a Comment